Literature DB >> 9183587

Importance of flow/metabolism studies in predicting late recovery of function following reperfusion in patients with acute myocardial infarction.

A Maes1, L Mortelmans, J Nuyts, G Bormans, M C Herregods, B Bijnens, F Van de Werf.   

Abstract

AIMS: Positron emission tomographic imaging is known to be a reliable indicator of viable myocardium in chronic heart disease. Its value in acute myocardial infarction has not been studied extensively. METHODS AND
RESULTS: Sixty-two patients receiving thrombolytic therapy were studied. Myocardial tissue flow and metabolism were measured at 5 days and 3 months. Recovery of left ventricular function was investigated with echocardiography or radionuclide ventriculography. In eight patients, normal flow was found in the infarct area at 5 days with no significant changes in flow, metabolism or function over the next 3 months. In 54 patients, impaired regional myocardial blood flow in the infarct zone was observed at 5 days. In 39 patients, there was a matching positron emission tomographic pattern, while in 15 the pattern was mismatched. None of the patients with a TIMI flow grade < 3 revealed recovery of left ventricular function. In seven out of 11 patients with TIMI 3 flow and a mismatching pattern, additional angioplasty was performed with functional improvement in six.
CONCLUSIONS: Recovery of ventricular function is exclusively found in patients with a TIMI flow grade 3. Patients with a positron emission tomographic mismatching pattern reveal functional recovery only after subsequent angioplasty.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9183587     DOI: 10.1093/oxfordjournals.eurheartj.a015384

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  7 in total

Review 1.  PET radiopharmaceuticals used in viability studies in acute myocardial infarction: a literature survey.

Authors:  Liesbet Mesotten; Alex Maes; Frans Van de Werf; Luc Mortelmans
Journal:  Eur J Nucl Med Mol Imaging       Date:  2001-11-14       Impact factor: 9.236

2.  PET myocardial perfusion and glucose metabolism imaging: Part 2-Guidelines for interpretation and reporting.

Authors:  Heinrich R Schelbert; Robert Beanlands; Frank Bengel; Juhani Knuuti; Marcelo Dicarli; Josef Machac; Randolph Patterson
Journal:  J Nucl Cardiol       Date:  2003 Sep-Oct       Impact factor: 5.952

3.  Contralateral angiography in acute myocardial infarction patients: is less really more?

Authors:  Marlos R Fernandes; Guilherme V Silva; Emerson C Perin
Journal:  Tex Heart Inst J       Date:  2012

4.  Prediction of left ventricular wall motion recovery after acute myocardial infarction by Tl-201 gated SPECT: incremental value of integrated contractile reserve assessment.

Authors:  Marcus Vinicius Simões; Oswaldo César de Almeida-Filho; Antonio Osvaldo Pintya; Alexandre Baldini de Figueiredo; Cleide Marques Antloga; Fernando Vilela Salis; Nadia de Paula Batista; Moysés de Oliveira Lima-Filho; Benedito Carlos Maciel; José Antonio Marin-Neto
Journal:  J Nucl Cardiol       Date:  2002 May-Jun       Impact factor: 5.952

5.  Development of myocardial microcirculation and metabolism in acute ST-elevation myocardial infarction evaluated with positron emission tomography.

Authors:  Gunnar Frostfeldt; Jens Sörensen; Bertil Lindahl; Sven Valind; Lars Wallentin
Journal:  J Nucl Cardiol       Date:  2005 Jan-Feb       Impact factor: 5.952

6.  Comparative assessment of 18F-fluorodeoxyglucose PET and 99mTc-tetrofosmin SPECT for the prediction of functional recovery in patients with reperfused acute myocardial infarction.

Authors:  Haruhisa Shirasaki; Akira Nakano; Hiroyasu Uzui; Yoshiharu Yonekura; Hidehiko Okazawa; Takanori Ueda; Jong-Dae Lee
Journal:  Eur J Nucl Med Mol Imaging       Date:  2006-04-04       Impact factor: 9.236

7.  Positron emission tomography myocardial perfusion and glucose metabolism imaging.

Authors:  Josef Machac; Stephen L Bacharach; Timothy M Bateman; Jeroen J Bax; Robert Beanlands; Frank Bengel; Steven R Bergmann; Richard C Brunken; James Case; Dominique Delbeke; Marcelo F DiCarli; Ernest V Garcia; Richard A Goldstein; Robert J Gropler; Mark Travin; Randolph Patterson; Heinrich R Schelbert
Journal:  J Nucl Cardiol       Date:  2006-11       Impact factor: 3.872

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.